[1]李凤国△ 张兰云 周志洁 许雪英 王娓娓 雷新峰 刘永建.关节内注射复方双氯芬酸钠治疗中重度 骨关节炎的临床研究[J].中国中医骨伤科杂志,2019,27(07):23-26.
　LI Fengguo ZHANG Lanyun ZHOU Zhijie XU Xueying WANG Weiwei LEI Xinfeng LIU Yongjian.Clinical Study of Intra-articular Injection of Compound Diclofenac Sodium in the Treatment of Moderate and Severe Osteoarthritis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2019,27(07):23-26.
点击复制

关节内注射复方双氯芬酸钠治疗中重度 骨关节炎的临床研究()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第27卷
期数:
2019年07期
页码:
23-26
栏目:
临床研究
出版日期:
2019-06-30

文章信息/Info

Title:
Clinical Study of Intra-articular Injection of Compound Diclofenac Sodium in the Treatment of Moderate and Severe Osteoarthritis
文章编号:
1005-0205(2019)07-0023-04
作者:
李凤国1△ 张兰云1 周志洁1 许雪英1 王娓娓1 雷新峰1 刘永建1
1河北衡水市人民医院(河北 衡水,053000)
Author(s):
LI Fengguo1△ ZHANG Lanyun1 ZHOU Zhijie1 XU Xueying1 WANG Weiwei1 LEI Xinfeng1 LIU Yongjian1
1People's Hospital of Hengshui City,Hengshui 053000,Hebei China.
关键词:
复方双氯芬酸钠;  中重度骨关节炎;  生存质量;  不良反应
Keywords:
compound diclofenac sodium;  moderate and severe osteoarthritis;  quality of life;  adverse reactions
分类号:
R684.3
文献标志码:
A
摘要:
目的:探究关节内注射复方双氯芬酸钠治疗中重度骨关节炎的临床应用价值。方法:选取2017年3月至2018年3月本院收治的中重度骨关节炎患者94例,采用随机字母表法随机分为2组,对照组及观察组各47例,对照组采用双氯芬酸钠利多卡因注射液治疗,观察组关节内注射复方双氯芬酸钠,对比两组患者总有效率、骨关节炎指数、生存质量及不良反应发生率,检测白细胞介素-1(IL-1)、肿瘤坏死因子-α(TNF-α)、前列腺素E2(PGE2)水平。结果:观察组经治疗后总有效率为95.74%明显较对照组78.72%高,差异有统计学意义(P<0.05); 两组经治疗后疼痛、僵硬、生理功能及总分均显著低于治疗前,且观察组较对照组低,差异有统计学意义(P<0.05); 两组经治疗后IL-1,TNF-ɑ及PGE2均显著低于治疗前,且观察组较对照组低,差异有统计学意义(P<0.05); 两组经治疗后世界卫生组织生存质量测定量表简表(WHOQOL-BREF)各项评分均显著高于治疗前,且观察组较对照组高,差异有统计学意义(P<0.05); 观察组不良反应发生率为10.64%,明显较对照组29.79%低,差异有统计学意义(P<0.05)。结论:中重度骨关节炎患者采用关节内注射复方双氯芬酸钠治疗效果显著,达到抗炎镇痛作用,明显缓解临床症状,提高生存质量,安全性更高,值得临床推广应用。
Abstract:
To explore the clinical application value of intra-articular injection of compound diclofenac sodium in the treatment of moderate and severe osteoarthritis.Methods:94 patients with moderate and severe osteoarthritis were selected from March 2017 to March 2018,random alphabet method was used to divide them into two groups randomly,47 cases in control group and 47 cases in observation group,the control group was treated with diclofenac sodium lidocaine injection,while the observation group was treated with compound diclofenac sodium intra-articular injection,the total effective rate,osteoarthritis index,quality of life and incidence of adverse reactions were compared between the two groups,the levels of interleukin-1(IL-1),tumor necrosis factor-α(TNF-α)and prostaglandin E2(PGE2)were measured.Results: After treatment,the total effective rate of the observation group was 95.74%,which was significantly higher than 78.72% of the control group(P<0.05).The pain,stiffness,physiological function and total scores of the two groups after treatment were significantly lower than those before treatment,and the observation group was lower than the control group(P<0.05).After treatment,the levels of IL-1,TNF-α and PGE2 in the two groups were significantly lower than those before treatment,and those in the observation group were lower than those in the control group(P<0.05); the scores of World Health Organization quality of life scale(WHOQOL-BREF)in the two groups after treatment were significantly higher than those before treatment,and the observation group were higher than the control group(P<0.05).The incidence of adverse reactions in the observation group was 10.64%,which was significantly lower than 29.79% in the control group(P<0.05).Conclusion:Intra-articular injection of compound diclofenac sodium is effective for moderate and severe osteoarthritis,it can achieve anti-inflammatory and analgesic effects,relieve clinical symptoms,improve the quality of life,and have higher safety,it is worthy of clinical application.

参考文献/References:

[1] 申筠.盐酸氨基葡萄糖治疗骨关节炎的效果观察[J].中国地方病防治杂志,2016,31(9):67-68.
[2] 史慧星,任伟,张永存,等.复方双氯芬酸钠和间苯三酚在宫腔镜检查中镇痛效果的观察[J].中国计划生育学杂志,2016,24(7):486-488.
[3] 中华医学会骨科学分会.骨关节炎诊治指南(2007年版)[J].中国矫形外科杂志,2014,27(3):28-30.
[4] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:349-353.
[5] THUMBOO J,CHEW L H,SOH C H.Validation of the Western Ontario and Mcmaster University osteoarthritis index in Asians with osteoarthritis in Singapore[J].Osteoarthritis Cartilage,2001,9(5):440-446.
[6] GROUP T W.Development of the world health organization WHOQOL-bref quality of life assessment 1998[J].Psychological Medicine,1998,28(3):551-558.
[7] 李云泽,赵序利.骨性关节炎发病机制研究进展[J].中国疼痛医学杂志,2016,22(10):728-733.
[8] 谷艳超,刘世清,夏韶强,等.骨关节炎发病机制和治疗的研究进展[J].中国骨与关节杂志,2016,5(10):770-774.
[9] 任鹏涛,张苑,阎庆辉,等.双氯芬酸钠利多卡因合用止痛剂治疗疼痛的疗效研究[J].中国现代医学杂志,2017,27(23):91-94.
[10] 耿倩,申乐.围术期持续静脉输注利多卡因在多模式镇痛中的应用和机制探讨[J].临床药物治疗杂志,2018,16(2):80-83.
[11] 朱艳,徐萍,王清,等.术后镇痛应用复方双氯芬酸钠注射液患者发生急性肾损伤风险及相关因素分析[J].药物不良反应杂志,2017,19(6):420-424.
[12] 赵天毓,朱昆,郭义明.肌肉注射复方双氯芬酸钠注射液致疑似脂膜炎1例并文献分析[J].中国实验诊断学,2018,22(3):469-470.
[13] TIEPPO F V,DAVANI S,TOWERY C,et al.Oral versus topical diclofenac sodium in the treatment of osteoarthritis[J].Journal of Pain & Palliative Care Pharmacotherapy,2017,31(4):1-8.
[14] 包杭生,李逸群,吴峰,等.补阳还五汤对膝骨性关节炎患者WOMAC评分及关节液TNF-α、PGE2、MMP-3水平的影响[J].广州中医药大学学报,2016,33(6):804-809.

备注/Memo

备注/Memo:
(收稿日期:2019-03-02)基金项目:衡水市科技计划项目(15016)△通信作者 E-mail:langweiyahlj@126.com
更新日期/Last Update: 2019-06-30